Ooyama T, Shimoji Y, Nakasone T, Arakaki Y, et al. Effects of Pegylated Liposomal Doxorubicin and CA125 Level Variability Analysis in Platinum-refractory/resistant Recurrent Ovarian Cancer. Anticancer Res 2022;42:3017-3022.
PMID: 35641257